The use of anti-EZH2 antibody conjugated liposomes in melanoma therapy targets the enhancer of zeste homolog 2 (EZH2), a pivotal protein in the epigenetic regulation of gene expression that promotes tumor progression. By selectively delivering therapeutic agents to cancer cells expressing high levels of EZH2, these liposomes aim to disrupt the oncogenic signaling pathways that contribute to tumor development and resistance to treatment. This innovative approach not only enhances the specificity of the therapy but also minimizes potential side effects associated with conventional treatments, ultimately improving patient outcomes in melanoma management.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-3981z | Mouse Anti-EZH2 Recombinant Antibody (clone 21F1) | WB, ELISA, FC, ICC, IHC | Mouse IgG1 |
VS3-QX394 | Mouse Anti-EZH2 Recombinant Antibody (clone 3D2A4) | WB, IHC, ICC, FC, ELISA | Mouse IgG1 |
VS3-QX395 | Mouse Anti-EZH2 Recombinant Antibody (clone 144CT2.1.1.5) | WB, ICC, IHC | Mouse IgG1, κ |
VS3-QX396 | Mouse Anti-EZH2 Recombinant Antibody (clone 6F-4G) | WB, IHC, FC | Mouse IgG1 |
VS3-FY526 | Recombinant Rabbit Anti-EZH2 Antibody (clone R07-5B1) | WB, ICC, IF | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY179. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.